Ruixin Lin

583 total citations
24 papers, 364 citations indexed

About

Ruixin Lin is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Ruixin Lin has authored 24 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Ruixin Lin's work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (3 papers). Ruixin Lin is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (3 papers). Ruixin Lin collaborates with scholars based in China, Singapore and United States. Ruixin Lin's co-authors include Shuli Yang, Lihui Si, Jiacheng Wu, Ruiqi Yang, Yan Jia, Xiaoxiao Yao, Xuewen Zhang, Shuai Ma, Shan Qiao and Min Wang and has published in prestigious journals such as Molecules, European Journal of Medicinal Chemistry and Seminars in Cancer Biology.

In The Last Decade

Ruixin Lin

23 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruixin Lin China 13 170 93 51 39 33 24 364
Mei‐Due Yang Taiwan 12 144 0.8× 102 1.1× 39 0.8× 39 1.0× 40 1.2× 32 353
Mostafa M. Elshafey Egypt 10 179 1.1× 160 1.7× 70 1.4× 39 1.0× 27 0.8× 14 450
Yuting Yang China 9 182 1.1× 65 0.7× 27 0.5× 45 1.2× 36 1.1× 17 446
Haiding Huang China 12 178 1.0× 60 0.6× 46 0.9× 38 1.0× 19 0.6× 16 426
Weifeng Hu China 12 181 1.1× 83 0.9× 62 1.2× 32 0.8× 48 1.5× 30 445
Lirui Sun China 12 163 1.0× 74 0.8× 55 1.1× 17 0.4× 19 0.6× 20 396
Weikang Guo China 11 229 1.3× 105 1.1× 24 0.5× 42 1.1× 28 0.8× 24 447
Vipendra Kumar Singh India 10 181 1.1× 64 0.7× 38 0.7× 25 0.6× 36 1.1× 26 443
Xiaohua Pei China 12 233 1.4× 59 0.6× 61 1.2× 26 0.7× 21 0.6× 48 426

Countries citing papers authored by Ruixin Lin

Since Specialization
Citations

This map shows the geographic impact of Ruixin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixin Lin more than expected).

Fields of papers citing papers by Ruixin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixin Lin. The network helps show where Ruixin Lin may publish in the future.

Co-authorship network of co-authors of Ruixin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixin Lin. A scholar is included among the top collaborators of Ruixin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixin Lin. Ruixin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Wu, Jiacheng, et al.. (2024). Enrichment and Evaluation of Antitumor Properties of Total Flavonoids from Juglans mandshurica Maxim. Molecules. 29(9). 1976–1976. 4 indexed citations
5.
Wang, Min, Lianwen Zheng, Shuai Ma, et al.. (2023). Cuproptosis: emerging biomarkers and potential therapeutics in cancers. Frontiers in Oncology. 13. 1288504–1288504. 25 indexed citations
6.
Yang, Shuli, et al.. (2023). Prognostic role of the peritoneal cancer index in ovarian cancer patients who undergo cytoreductive surgery: a meta-analysis. Current Problems in Cancer. 47(6). 101014–101014. 5 indexed citations
7.
Wang, Min, Lianwen Zheng, Shuai Ma, et al.. (2023). Biogenesis and function of exosome lncRNAs and their role in female pathological pregnancy. Frontiers in Endocrinology. 14. 1191721–1191721. 13 indexed citations
8.
Wang, Min, Lianwen Zheng, Ruixin Lin, et al.. (2023). A comprehensive overview of exosome lncRNAs: emerging biomarkers and potential therapeutics in endometriosis. Frontiers in Endocrinology. 14. 1199569–1199569. 8 indexed citations
9.
10.
Lin, Ruixin, et al.. (2021). LncRNA SNHG14 Sponges miR-206 to Affect Proliferation, Apoptosis, and Metastasis of Hepatocellular Carcinoma Cells by Regulating SOX9. Digestive Diseases and Sciences. 67(3). 936–946. 13 indexed citations
11.
Wu, Jiacheng, et al.. (2021). Endoplasmic reticulum stress: Multiple regulatory roles in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 142. 112005–112005. 37 indexed citations
12.
Lin, Ruixin, et al.. (2021). Epigenetic regulation of papillary thyroid carcinoma by long non-coding RNAs. Seminars in Cancer Biology. 83. 253–260. 33 indexed citations
13.
Zhang, Hong, et al.. (2021). Epigenetic signature associated with thyroid cancer progression and metastasis. Seminars in Cancer Biology. 83. 261–268. 10 indexed citations
14.
Wu, Jiacheng, Guofeng Zhang, Xiaoxiao Yao, et al.. (2020). Achilles’heel of laparoscopic pancreatectomy: reconstruction of the remnant pancreas. Expert Review of Gastroenterology & Hepatology. 14(7). 527–537. 4 indexed citations
15.
16.
Yang, Shuli, Ruixin Lin, Lihui Si, et al.. (2019). Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial. Journal of Diabetes Research. 2019. 1–13. 16 indexed citations
17.
Jia, Yan, et al.. (2019). Thiophenol-formaldehyde triazole causes apoptosis induction in ovary cancer cells and prevents tumor growth formation in mice model. European Journal of Medicinal Chemistry. 172. 62–70. 10 indexed citations
18.
Li, Yuhui, Shuli Yang, Guofeng Zhang, et al.. (2018). Mefloquine targets β -catenin pathway and thus can play a role in the treatment of liver cancer. Microbial Pathogenesis. 118. 357–360. 14 indexed citations
19.
Lin, Ruixin, et al.. (2015). Erratum: Role of ursolic acid chalcone, a synthetic analogue of ursolic acid, in inhibiting the properties of CD133(+) sphere-forming cells in liver stem cells.. PubMed. 14(2). 1427–34. 6 indexed citations
20.
Lin, Ruixin, et al.. (1993). A Case Report and Review of the Literature. American Journal of Dermatopathology. 15(1). 82–84. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei‐Due Yang Breakdown of academic impact, for papers by Mostafa M. Elshafey Breakdown of academic impact, for papers by Yuting Yang Breakdown of academic impact, for papers by Haiding Huang Breakdown of academic impact, for papers by Weifeng Hu Breakdown of academic impact, for papers by Lirui Sun Breakdown of academic impact, for papers by Weikang Guo Breakdown of academic impact, for papers by Vipendra Kumar Singh Breakdown of academic impact, for papers by Xiaohua Pei
Rankless by CCL
2026